Form 8.3 - Aon plc
Ap19
Â
Â
FORMÂ 8.3
Â
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
DEALINGSÂ BYÂ PERSONSÂ WITHÂ INTERESTSÂ INÂ RELEVANTÂ SECURITIESÂ REPRESENTINGÂ 1%Â ORÂ MORE
Â
1.      KEY INFORMATION
Â
Name of person dealing (Note 1) | Â GIC Private Limited |
Company dealt in | Â Aon plc |
Class of relevant security to which the dealings being disclosed relate (Note 2) | Â Ordinary Shares |
Date of dealing | Â 02 Jul 2020 |
Â
2.        INTERESTS AND SHORT POSITIONS
Â
(a)       Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 | Long | Short | ||||
 | Number |  | (%) | Number |  | (%) |
(1) Relevant securities - Ordinary Shares | Â Â 4,377,568 (1.8908%) | - | ||||
(2) Derivatives (other than options) | - | - | ||||
(3) Options and agreements to purchase/sell | - | - | ||||
Total | 4,377,568 (1.8908%) | - | ||||
 |  |  |  |  |  |  |
Â
(b)       Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
 | Number |  | (%) | Number |  | (%) |
(1) Relevant securities - Preferred Shares | - | - | ||||
 (2) Derivatives (other than options) | - | - | ||||
 (3) Options and agreements to purchase/sell | - | - | ||||
Total | - | - | ||||
 |  |  |  |  |  |  |
Â
Ap20
Â
Â
1.      DEALINGS (Note 4)
Â
(a)     Purchases and sales
Â
 Purchase/sale |  Number of relevant securities |  Price per unit (Note 5) |
 Purchase |          233          ordinary shares |   USD 191.45 |
 Purchase |          424         ordinary shares |   USD 191.23 |
 Purchase |         1,032       ordinary shares |   USD 192.02 |
 Purchase |         1,062       ordinary shares |   USD 191.23 |
 Purchase |         2,582       ordinary shares |   USD 192.02 |
 Purchase |           582        ordinary shares |   USD 191.45 |
 Sale |           553        ordinary shares |   USD 193.75 |
 |  |  |
Â
(b)     Derivatives transactions (other than options transactions)
Â
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
 |  |  |  |
Â
(c)     Options transactions in respect of existing relevant securities
Â
Â
(i)      Writing, selling, purchasing or varying
Â
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
 |  |  |  |  |  |  |
Â
(ii)Â Â Â Â Â Exercising
Â
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
 |  |  |
Â
(d)     Other dealings (including transactions in respect of new securities) (Note 4)
Â
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
 |  |  |
Â
Ap21
Â
2.      OTHER INFORMATION
Â
Agreements, arrangements or understandings relating to options or derivatives
Â
Â
Â
Â
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivativeÂ
referred to on this form is referenced. If none, this should be stated.
Â
Â
Â
Â
Â
Â
Â
Â
Â
Â
Is a Supplemental Form 8 attached? (Note 9)                                           YES/NO
Â
Date of disclosure | 03 Jul 2020 |
Contact name | Celine Loh |
Telephone number | (65) 6889 8952 |
If a connected EFM, name of offeree/offeror with which connected | NA |
If a connected EFM, state nature of connection (Note 10) | NA |
Â
Â
Â
Â
Â
Â
Â
This announcement has been issued through the Companies Announcement Service of Euronext Dublin.
Â
Â
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.